Study of Magnetic Fields to Treat Alzheimer's Disease

Inclusion Criteria: To be considered eligible for participation in this clinical study, a subject must satisfy each of the following "Inclusive Conditions" criteria. * Current diagnosis of Alzheimer's Disease appropriately documented by the patients physician and/or neurologist * Documentation verifying that other generally recognized causes of dementia have been ruled out by prior physician evaluations * Mild to Moderate Dementia, as evidenced by a score of not less than 12 nor greater than 26 on the Mini Mental Status Exam (MMSE). * Subject is ambulatory * A Study Partner who can attend all study visits with the subject. Study Partner being defined as an adult who has at least 10 hours/week of contact with the subject, and can accompany the subject to all testing and treatment study visits. * Stable "anti-dementia" medication regimen without significant side effects for at least 3 months, and on stable medication (unrelated to anti-dementia) without significant side effects for at least 1 month; willingness and ability to maintain the stable medication regimen throughout the course of the study. * Willingness and ability to present to the testing center for all study evaluations * Willingness and ability to present to the treatment center for all study treatments (exposure to the Resonator™) * Willingness to maintain stable diet and activity regimen for the duration of the study. * Willing and able to abstain from partaking in any non-essential (not physician ordered) existing or new treatments to improve cognition and mental functioning * Willing and able to abstain from any medications that could affect cognition and mental functioning during the course of the study * Male or female. * Any ethnic background. * Age 55 and older. Exclusion Criteria A subject will be considered ineligible for participation in this clinical study if he or she satisfies any one or more of the following exclusive conditions criteria. * Change in anti-dementia medical regimen within 3 months prior to initiation of study. * Confirmed diagnosis other non-Alzheimer's type of dementia * Significant neurologic or psychiatric illness other than Alzheimer's disease * Unstable cardiac disease, such as any history of cardiac arrhythmias (including atrial fibrillation, ventricular fibrillation, or irregular atrial-ventricular conduction time), or any incidences of congestive heart failure, or myocardial infarction, within the last six months. * Previous surgical interventions involving prosthetics or implants comprised of ferrous metals, or pacemakers, vagus nerve stimulators, or other functional electrical stimulators such as those commonly used for pain. * Reported consumption of more than 14 alcoholic drinks per week. * Uncontrolled hypertension. * Uncontrolled atrial fibrillation or other uncontrolled arrhythmias, e.g. tachycardia, bradycardia. * Uncontrolled seizure disorder. * History of seizures or usage of anti-seizure medications that, in the opinion of the investigator, participation in this trial would represent a risk to the subject. * Uncontrolled, unstable, or untreated medical conditions which may significantly impact the subject's health or ability to complete the entire study, in the opinion of the investigator.